0001956559-22-000001.txt : 20221201 0001956559-22-000001.hdr.sgml : 20221201 20221130205535 ACCESSION NUMBER: 0001956559-22-000001 CONFORMED SUBMISSION TYPE: D PUBLIC DOCUMENT COUNT: 1 ITEM INFORMATION: 06b FILED AS OF DATE: 20221201 DATE AS OF CHANGE: 20221130 EFFECTIVENESS DATE: 20221201 FILER: COMPANY DATA: COMPANY CONFORMED NAME: Rezo Therapeutics, Inc. CENTRAL INDEX KEY: 0001956559 IRS NUMBER: 874039235 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: D SEC ACT: 1933 Act SEC FILE NUMBER: 021-466228 FILM NUMBER: 221437046 BUSINESS ADDRESS: STREET 1: 455 MISSION BAY BOULEVARD SOUTH STREET 2: SUITE 525 CITY: SAN FRANCISCO STATE: CA ZIP: 94158 BUSINESS PHONE: 415-310-4524 MAIL ADDRESS: STREET 1: 455 MISSION BAY BOULEVARD SOUTH STREET 2: SUITE 525 CITY: SAN FRANCISCO STATE: CA ZIP: 94158 D 1 primary_doc.xml X0708 D LIVE 0001956559 Rezo Therapeutics, Inc. 455 MISSION BAY BOULEVARD SOUTH SUITE 525 SAN FRANCISCO CA CALIFORNIA 94158 415-310-4524 DELAWARE None None Corporation true 2021 Nevan Krogan C/O REZO THERAPEUTICS, INC. 455 MISSION BAY BOULEVARD SOUTH, STE 525 SAN FRANCISCO CA CALIFORNIA 94158 Executive Officer Director Promoter Sourav Bandyopadhyay C/O REZO THERAPEUTICS, INC. 455 MISSION BAY BOULEVARD SOUTH, STE 525 SAN FRANCISCO CA CALIFORNIA 94158 Executive Officer Promoter Vineeta Agarwala C/O REZO THERAPEUTICS, INC. 455 MISSION BAY BOULEVARD SOUTH, STE 525 SAN FRANCISCO CA CALIFORNIA 94158 Director Tiba Aynechi C/O REZO THERAPEUTICS, INC. 455 MISSION BAY BOULEVARD SOUTH, STE 525 SAN FRANCISCO CA CALIFORNIA 94158 Director Norbert Bischofberger C/O REZO THERAPEUTICS, INC. 455 MISSION BAY BOULEVARD SOUTH, STE 525 SAN FRANCISCO CA CALIFORNIA 94158 Director Simeon George C/O REZO THERAPEUTICS, INC. 455 MISSION BAY BOULEVARD SOUTH, STE 525 SAN FRANCISCO CA CALIFORNIA 94158 Director George Scangos C/O REZO THERAPEUTICS, INC. 455 MISSION BAY BOULEVARD SOUTH, STE 525 SAN FRANCISCO CA CALIFORNIA 94158 Director Biotechnology Decline to Disclose 06b false 2022-07-21 false true false 0 80129936 14616238 65513698 This filing covers the sale and purchase of Series A Preferred Stock, and the Common Stock issuable upon conversion thereof. false 20 0 0 0 false Rezo Therapeutics, Inc. /s/ Sourav Bandyopadhyay Sourav Bandyopadhyay Chief Scientific Officer 2022-11-30